At a glance
ClinicalIndex Comparison RecordN/ACompleted· 20 enrolled
Drug / intervention
Hearing Aid Signia Pure C&G 7IX +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Standard PMCF Study WSA @ HZO
In Brief
A clinical study evaluating Hearing Aid Signia Pure C&G 7IX and Own Hearing Aid for Hearing Loss, Sensorineural. Completed, enrolled 20 participants across 1 site.
Detailed Summary
The purpose of the study is to follow-up on a released low-risk device as part of standard PMCF activities
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHearing Loss, Sensorineural
CountriesGermany
Collaborators--
Timeline
N/ACompletedFinished
20252026
Enrollment StartJun 2024
Primary CompletionAug 2024
Study CompletionAug 2024
First PostedNov 2024
TodayJul 2026
First PostedNov 22, 2024
Enrollment StartJun 14, 2024
Primary CompletionAug 13, 2024
Study CompletionAug 26, 2024
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 1.6 years ago
Interventions
Hearing Aid Signia Pure C&G 7IXdevice
Receiver in Canal (RIC) hearing aid, M Receiver
Own Hearing Aiddevice
subjects' own hearing aids, any brand, any model